or Try an Advanced Search...

    Treatment Of Breast Cancer Stocks List

    Symbol Grade Name % Change
    ACHV B Achieve Life Sciences, Inc. -1.06
    BPTH F Bio-Path Holdings Inc 2.55
    BCTX F BriaCell Therapeutics Corp. 0.88
    CLDX C Celldex Therapeutics, Inc. -1.55
    CHRS F Coherus BioSciences, Inc. -3.96
    CRIS B Curis, Inc. -1.61
    GTHX B G1 Therapeutics, Inc. -4.23
    GLSI D Greenwich LifeSciences, Inc. 0.97
    HOLX B Hologic, Inc. -0.63
    MACK B Merrimack Pharmaceuticals, Inc. 0.10
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies Software - Application
    Related Stock Lists: Breast Cancer Biopharmaceutical Cancer Medicine Biotechnology Clinical Medicine Acid Her2 Her2/Neu Immunotherapy Solid Tumors Treatment Of Cancer Advanced Breast Cancer Cancer Cell Cancer Center Cancer Treatment Chemotherapy Clinical Development Drugs Immune System

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Breast Cancer stocks.

    Symbol Grade Name Weight
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 1.64
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 1.31
    CNCR D Loncar Cancer Immunotherapy ETF 1.05
    SBIO D ALPS Medical Breakthroughs ETF 0.87
    XBI D SPDR S&P Biotech ETF 0.77
    View all Treatment Of Breast Cancer ETFs...
    Compare ETFs
    Compare BBC to XBI Compare CNCR to SBIO Compare SBIO to XBI

        Treatment Of Breast Cancer Stocks Recent News

        Date Stock Title
        May 6 CRIS Curis Q1 2024 Earnings Preview
        May 5 HOLX Hologic Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        May 4 GTHX G1 Therapeutics, Inc. (NASDAQ:GTHX) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
        May 3 HOLX Hologic, Inc. (NASDAQ:HOLX) Q2 2024 Earnings Call Transcript
        May 3 HOLX Hologic's (HOLX) Q2 Earnings Beat Estimates, 2024 View Up
        May 3 HOLX Q2 2024 Hologic Inc Earnings Call
        May 3 GTHX G1 Therapeutics First Quarter 2024 Earnings: Revenues Disappoint
        May 3 HOLX Hologic, Inc. (HOLX) Q2 2024 Earnings Call Transcript
        May 3 HOLX Hologic (HOLX) Reports Q2 Earnings: What Key Metrics Have to Say
        May 2 HOLX Hologic Inc. (HOLX) Surpasses Q2 Fiscal 2024 Earnings and Revenue Estimates
        May 2 HOLX Hologic (HOLX) Q2 Earnings and Revenues Beat Estimates
        May 2 HOLX Hologic Fiscal Q2 Earnings, Revenue Decline; Q3 Outlook Issued, Fiscal 2024 Estimates Revised -- Shares Up After Hours
        May 2 HOLX Hologic Non-GAAP EPS of $1.03 beats by $0.05, revenue of $1.02B beats by $20M
        May 2 HOLX Hologic Announces Financial Results for Second Quarter of Fiscal 2024
        May 2 GTHX G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript
        May 2 GTHX G1 Therapeutics Inc (GTHX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...
        May 2 GTHX Q1 2024 G1 Therapeutics Inc Earnings Call
        May 1 HOLX Hologic Q2 2024 Earnings Preview
        May 1 CHRS Coherus to Report First Quarter 2024 Financial Results on May 9, 2024
        May 1 BPTH Looking Into Bio-Path Hldgs's Recent Short Interest
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies Software - Application
        Related Stock Lists: Breast Cancer Medicine Cancer Biopharmaceutical Biotechnology Clinical Medicine Her2 Her2/Neu Epidermal Growth Factor Receptor Immunotherapy Oncology Advanced Breast Cancer Antiestrogens Clinical Development Clinical Trial Drugs Estrogen Estrogen Receptor Hormones Prostate Cancer
        Treatment Of Breast Cancer

        Treatment of breast cancer depends on the type and stage of the cancer, as well as the patient's age, overall health, and personal preferences. Treatment options may include surgery, radiation therapy, chemotherapy, hormone therapy, targeted therapy, and/or immunotherapy.

        Browse All Tags